Renovion's Unattributed - II Round

Renovion raised a round of funding on May 15, 2018.

Renovion is a pre-clinical stage pharmaceutical company with a therapy for chronic inflammatory airway diseases. The company's goal is to be the first drug ever approved for patients that have receive…

Articles about Renovion's Unattributed - II Round: